TITLE

Evaluation of "Increased" Hemoglobin in the JAK2 Mutations Era: A Diagnostic Algorithm Based on Genetic Tests

AUTHOR(S)
Tefferi, Ayalew; Pardanani, Animesh
PUB. DATE
May 2007
SOURCE
Mayo Clinic Proceedings;May2007, Vol. 82 Issue 5, p599
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Recent discoveries in the molecular pathogenesis of both polycythemia vera (PV) and congenital polycythemia (CP) underline the prospect of a genetic diagnosis in these disorders. At the forefront are the mutually exclusive exon 14 (JAK2V617F) and exon 12 JAK2 mutations that are almost always present in PV but not in polycythemias of other causes. Similarly, the molecular basis of CP is being unraveled, and several cases are now associated with germline mutations involving the von Hippel-Lindau (VHL) or erythropoletin receptor (EPOR) genes. Therefore, current diagnostic work-up for acquired polycythemia should start with peripheral blood JAK2 mutation screening, whereas VHL and/or EPOR mutations should be considered when CP is suspected. In all instances, serum erythropoletin measurement provides complementary information; the serum erythropoletin level is expected to be decreased in PV regardless of JAK2 mutation status, increased in VHL mutation-associated CP, and decreased or normal in the presence of an EPOR mutation.
ACCESSION #
25242039

 

Related Articles

  • Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy. Taniguchi-Ikeda, Mariko; Kobayashi, Kazuhiro; Kanagawa, Motoi; Yu, Chih-chieh; Mori, Kouhei; Oda, Tetsuya; Kuga, Atsushi; Kurahashi, Hiroki; Akman, Hasan O.; DiMauro, Salvatore; Kaji, Ryuji; Yokota, Toshifumi; Takeda, Shin'ichi; Toda, Tatsushi // Nature;10/6/2011, Vol. 478 Issue 7367, p127 

    Fukuyama muscular dystrophy (FCMD; MIM253800), one of the most common autosomal recessive disorders in Japan, was the first human disease found to result from ancestral insertion of a SINE-VNTR-Alu (SVA) retrotransposon into a causative gene. In FCMD, the SVA insertion occurs in the 3?...

  • A germline JAK2 SNP is associated with predisposition to the development of JAK2V617F-positive myeloproliferative neoplasms. Kilpivaara, Outi; Mukherjee, Semanti; Schram, Alison M.; Wadleigh, Martha; Mullally, Ann; Ebert, Benjamin L.; Bass, Adam; Marubayashi, Sachie; Heguy, Adriana; Garcia-Manero, Guillermo; Kantarjian, Hagop; Offit, Kenneth; Stone, Richard M.; Gilliland, D Gary; Klein, Robert J.; Levine, Ross L. // Nature Genetics;Apr2009, Vol. 41 Issue 4, p455 

    Polycythemia vera, essential thrombocythemia and primary myelofibrosis are myeloproliferative neoplasms (MPN) characterized by multilineage clonal hematopoiesis. Given that the identical somatic activating mutation in the JAK2 tyrosine kinase gene (JAK2V617F) is observed in most individuals with...

  • Biallelic MLH1 SNP cDNA expression or constitutional promoter methylation can hide genomic rearrangements causing Lynch syndrome. Morak, Monika; Koehler, Udo; Schackert, Hans Konrad; Steinke, Verena; Royer-Pokora, Brigitte; Schulmann, Karsten; Kloor, Matthias; H+ACYAIw-x00F6+ADs-chter, Wilhelm; Weingart, Josef; Keiling, Cortina; Massdorf, Trisari; Holinski-Feder, Elke // Journal of Medical Genetics;Aug2011, Vol. 48 Issue 8, p513 

    Background A positive family history, germline mutations in DNA mismatch repair genes, tumours with high microsatellite instability, and loss of mismatch repair protein expression are the hallmarks of hereditary non-polyposis colorectal cancer (Lynch syndrome). However, in w10e15% of cases of...

  • The mutation profile of JAK2 and CALR in Chinese Han patients with Philadelphia chromosome-negative myeloproliferative neoplasms. Zhiyuan Wu; Xinju Zhang; Xiao Xu; Yuming Chen; Tingting Hu; Zhihua Kang; Shibao Li; Hua Wang; Weiwei Liu; Xiaochao Ma; Ming Guan // Journal of Hematology & Oncology;2014, Vol. 7 Issue 1, p1 

    Mutations in JAK2, MPL and CALR are highly relevant to the Philadelphia chromosome (Ph)-negative myeloproliferative neoplasms (MPNs). We performed high resolution melting analysis and Sanger sequencing together with T-A cloning to elucidate the unique mutation profile of these genes, in Chinese...

  • Acquired familial Mediterranean fever associated with a somatic MEFV mutation in a patient with JAK2 associated postpolycythemia myelofibrosis. Shinar, Yael; Tohami, Tali; Livneh, Avi; Schiby, Ginette; Hirshberg, Abraham; Nagar, Meital; Goldstein, Itamar; Cohen, Rinat; Kukuy, Olga; Shubman, Ora; Sharabi, Yehonatan; Gonzalez-Roca, Eva; Arostegui, Juan I.; Rechavi, Gideon; Amariglio, Ninnette; Salomon, Ophira // Orphanet Journal of Rare Diseases;Jul2015, Vol. 10 Issue 1, p1 

    Background: A study was designed to identify the source of fever in a patient with post-polycythemia myelofibrosis, associated with clonal Janus Kinase 2 (JAK2) mutation involving duplication of exon 12. The patient presented with 1-2 day long self-limited periodic episodes of high fever that...

  • LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations. Pardanani, A.; Lasho, T.; Finke, C.; Oh, S. T.; Gotlib, J.; Tefferi, A. // Leukemia (08876924);Oct2010, Vol. 24 Issue 10, p1713 

    LNK mutation analysis was performed in 61 patients with blast-phase myeloproliferative neoplasms (MPN); post-primary myelofibrosis (PMF) in 41, post-polycythemia vera in 11 and post-essential thrombocythemia in 9 patients. Paired chronic-blast phase sample analysis was possible in 26 cases. Nine...

  • Molecular Pathology of Hereditary Diffuse Gastric Cancer. Odegaard, Justin I.; Schrijver, Iris // Journal of Cancer Therapy;Apr2013, Vol. 4 Issue 2, p554 

    Hereditary diffuse gastric cancer is a rare, autosomal dominant hereditary cancer syndrome associated with germline mutations in CDH1 in which 60% - 80% of affected individuals develop advanced diffuse gastric cancer, many as young adults. At clinical presentation, ~90% of these malignancies...

  • The gene encoding hematopoietic cell phosphatase (SHP-1) is structurally and transcriptionally intact in polycythemia vera. Asimakopoulos, Fotios A; Hinshelwood, Stephen; Gilbert, James GR; Delibrias, Catherine C; Göttgens, Berthold; Fearon, Douglas T; Green, Anthony R // Oncogene;3/13/97, Vol. 14 Issue 10, p1215 

    Polycythemia vera (PV) is an acquired clonal disorder characterized by increased production of mature red cells and growth of erythroid colonies in the absence of erythropoietin. Mutation of the erythropoietin receptor has been demonstrated to cause familial polycythemia, but no mutations have...

  • Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera. Pardanani, A.; Lasho, T. L.; Finke, C.; Hanson, C. A.; Tefferi, A. // Leukemia (08876924);Sep2007, Vol. 21 Issue 9, p1960 

    After accounting for misdiagnosis and treatment effect, allele-specific (AS)-PCR detects the JAK2V617F mutation in >95% of polycythemia vera (PV) patients. Using database inquiry, we identified 6 of a total 220 cases with PV that were JAK2V617F-negative (prevalence=3%). Of these, five cases...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics